2023
Approaches to pandemic prevention – the chromatin vaccine
Zhang J, Askenase P, Jaenisch R, Crumpacker C. Approaches to pandemic prevention – the chromatin vaccine. Frontiers In Immunology 2023, 14: 1324084. PMID: 38143744, PMCID: PMC10739501, DOI: 10.3389/fimmu.2023.1324084.Peer-Reviewed Original ResearchConceptsEffective vaccineViral infectionCoronavirus diseaseImmunodeficiency syndromeHIV DNASuccessful vaccinePolio vaccineHIV integrationVaccineNext pandemicViral replicationIneffective vaccinesInfectionEpisomal formFuture pandemicsCurrent pandemicPandemic preventionPreventionPandemicEnd productsEpigenetic silencingSyndromeDiseaseHuman population
2021
Rare Skin Reactions after mRNA Vaccination, Similar to Jones–Mote Basophil Responses
Askenase PW. Rare Skin Reactions after mRNA Vaccination, Similar to Jones–Mote Basophil Responses. New England Journal Of Medicine 2021, 385: 1720-1721. PMID: 34706177, PMCID: PMC8609603, DOI: 10.1056/nejmc2111452.Peer-Reviewed Original ResearchExosomes provide unappreciated carrier effects that assist transfers of their miRNAs to targeted cells; I. They are ‘The Elephant in the Room’
Askenase PW. Exosomes provide unappreciated carrier effects that assist transfers of their miRNAs to targeted cells; I. They are ‘The Elephant in the Room’. RNA Biology 2021, 18: 2038-2053. PMID: 33944671, PMCID: PMC8582996, DOI: 10.1080/15476286.2021.1885189.Peer-Reviewed Original ResearchConceptsExtracellular vesiclesAcceptor cellsOuter membrane vesiclesMiRNA transferMolecular chemical changesNano-extracellular vesiclesCargo moleculesExosome transferMembrane vesiclesMiRNAsGenetic expressionDNA expressionExosomesVesiclesCell functionIntracellular effectsFunctional effectsFunctional alterationsMolecular transferCellsPhysiologic processesLight chainExpressionMitochondriaBiology
2013
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity
Bryniarski K, Ptak W, Jayakumar A, Püllmann K, Caplan MJ, Chairoungdua A, Lu J, Adams BD, Sikora E, Nazimek K, Marquez S, Kleinstein SH, Sangwung P, Iwakiri Y, Delgato E, Redegeld F, Blokhuis BR, Wojcikowski J, Daniel AW, Kormelink T, Askenase PW. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. Journal Of Allergy And Clinical Immunology 2013, 132: 170-181.e9. PMID: 23727037, PMCID: PMC4176620, DOI: 10.1016/j.jaci.2013.04.048.Peer-Reviewed Original ResearchConceptsCutaneous contact sensitivityEffector T cellsT cell toleranceT cellsExosome-like nanovesiclesContact sensitivityCS-effector T cellsMiRNA-150Regulatory T cellsAntigen-specific mannerSuppressor T cellsRole of antibodiesAdoptive cell transfer modelCell transfer modelT cell regulationLight chainSuppressor cellsLymph nodesReactive haptenImmune suppressionMicroRNA-150Systemic injectionAntibody light chainIntravenous injectionSpleen cells
2007
c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection
Pedra JH, Mattner J, Tao J, Kerfoot SM, Davis RJ, Flavell RA, Askenase PW, Yin Z, Fikrig E. c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection. Infection And Immunity 2007, 76: 308-316. PMID: 17998313, PMCID: PMC2223674, DOI: 10.1128/iai.00599-07.Peer-Reviewed Original ResearchConceptsIFN-gamma productionA. phagocytophilum infectionPhagocytophilum infectionIFN-gammaJnk2-null miceNatural killer T cellsA. phagocytophilumKiller T cellsIFN-gamma releaseIFN-gamma secretionGamma interferon productionT cell agonistsAnaplasma phagocytophilum infectionT cellsEarly eradicationGamma interferonInterferon productionInfectionC-Jun NH2-terminal kinase-2Inhibitory effectElevated levelsMiceAnaplasma phagocytophilumPhagocytophilumKinase 2
1999
C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S, Robinson D, Meng Q, Barata L, McEuen A, Buckley M, Walls A, Askenase P, Kay A. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). The Journal Of Immunology 1999, 163: 3976-84. PMID: 10491000, DOI: 10.4049/jimmunol.163.7.3976.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAllergensBasophilsCell MovementChemokine CCL11Chemokine CCL24Chemokine CCL5Chemokine CCL7Chemokines, CCCytokinesDermatitis, AtopicEosinophiliaEosinophilsHumansImmunophenotypingMiddle AgedMonocyte Chemoattractant ProteinsReceptors, CCR3Receptors, ChemokineRNA, MessengerTime FactorsConceptsMonocyte chemoattractant protein-3C-C chemokinesEotaxin-2MCP-4T cellsAtopic subjectsLate-phase cutaneous responseCD4+ T cellsEotaxin receptor CCR3Human atopic subjectsMonocyte chemoattractant protein-4CD3+ cellsCD68+ macrophagesEG2+ eosinophilsExpression of eotaxinCCR3+ cellsMCP-4 mRNAElastase+ neutrophilsLate eosinophiliaAllergic tissue reactionsEotaxin proteinCD3+Allergen-inducedRelationship of expressionEotaxin mRNA